Skip to main content Deutsch

Marta Rizzi – Contact & CV

Institute of Immunology

Contact

©Arno Rottal

Univ.-Prof.in Dr.in Marta Rizzi, MD PhD

Medical University of Vienna
Division of Clinical and Experimental Immunology
Institute of Immunology
Center for Pathophysiology, Infectiology and Immunology
Lazarettgasse 19
1090 Vienna, Austria
Phone.: +43 1 40160-33271

E-Mail: marta.rizzi@meduniwien.ac.at

Biosketch

After studying Medicine at the University of Genoa/Italy, Marta Rizzi completed her PhD in Clinical and Experimental Immunology in Genoa/Italy and San Diego/California in 2004. In 2007, she completed her residency training in Allergology and Clinical Immunology. Since 2006, she has been conducting research at the University Medical Center Freiburg - initially as a postdoctoral fellow, and later as head of a research group since 2014. In 2014, she was awarded the prestigious Margarete von Wrangell fellowship.

Since 2022 she is Professor of Clinical and Experimental Immunology at the Medical University of Vienna.

She has been awarded the prestigious Heisenberg Professorship of the German Research foundation (DFG) and since 2023 she is also Professor for Experimental and Translational Rheumatology (Heisenberg) at the Faculty of Medicine of the University of Freiburg.

Marta Rizzi research focus is human B-lymphocytes development, maturation and activation in physiological and pathological conditions. She has developed unique expertise in in vitro modelling of early and late human B cell development, that she uses: to uncover mechanisms of disease in monogenic defects leading to autoimmunity; to study the B cell function in more complex rheumatological diseases; to assess the specific impact on human B lymphocytes of novel targeted therapies.

Marta Rizzi is elected member of the DFG Study group 204 ‘Microbiology, Virology and Immunology’, she is member of the organizing faculty of the European B cell network (EBCnet) school; of the Executive Board Member of Hans Hench Stiftung for rheumatology research; of the selection committee for clinician scientist programs (IMMEDIATE) and of the medical scientist program (Hans A. Krebs) from the Medical Faculty of the University of Freiburg, of the steering committee of the SFB1160 IMPATH and of the SFB/TRR 353 Apoptosis. Between 2014-2023 she has been speaker of the B-cell study group of the German Society of Immunology (DGfI); from 2010-2014 she has been executive Board Member of European Society of Immunodeficiency (ESID) and Chair of ESID Junior working party.

Curriculum Vitae (download)